THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans Pacific Partnership (TPP) trade agreement and biologics issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Taxation/Internal Revenue Code TAX
Tax extenders - HR 2029, Consolidated Appropriations Act, 2016. Comprehensive tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Health Issues HCR
21st Century Cures - HR 6, 21st Century Cures Act; proposed legislation (Senate Innovation Project). Healthcare issues included in reconciliation bill - HR 3762, Restoring Americans' Healthcare Freedom Reconciliation Act of 2015. Issues affecting healthcare in Omnibus Appropriations bill - HR 2029, Consolidated Appropriations Act, 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH DUBERSTEIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Budget/Appropriations BUD
Budget caps and the debt limit - HR 1314, Bipartisan Budget Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.